PlainRecalls
FDA Devices Moderate Class II Terminated

Elecsys CA 19-9, Cat. No. 07027028190 - Product Usage: the product is an immunoassay for monitoring and management of pancreatic cancer

Reported: March 11, 2020 Initiated: February 7, 2020 #Z-1444-2020

Product Description

Elecsys CA 19-9, Cat. No. 07027028190 - Product Usage: the product is an immunoassay for monitoring and management of pancreatic cancer

Reason for Recall

The firm has received an increased number of complaints concerning non-reproducible elevated results ("high flyers") for one lot of Elecsys CA 19-9 reagent, which may affect clinical interpretation.

Details

Units Affected
684
Distribution
US Nationwide distribution in the states of AL, AZ, CA, CO, FL, HI, IL, IN, KS, KY, MA, ME, MI, NC, NH, NJ, NY, TN, TX, WA and WI.
Location
Indianapolis, IN

Frequently Asked Questions

What product was recalled?
Elecsys CA 19-9, Cat. No. 07027028190 - Product Usage: the product is an immunoassay for monitoring and management of pancreatic cancer. Recalled by Roche Diagnostics Operations, Inc.. Units affected: 684.
Why was this product recalled?
The firm has received an increased number of complaints concerning non-reproducible elevated results ("high flyers") for one lot of Elecsys CA 19-9 reagent, which may affect clinical interpretation.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 11, 2020. Severity: Moderate. Recall number: Z-1444-2020.